Estrogens and androgens affect human luteal cell function

Slides:



Advertisements
Similar presentations
Raloxifene⁎ increases proliferation of human endothelial cells in association with increased gene expression of cyclins A and B1  Pilar J. Oviedo, B.Sc.,
Advertisements

Direct vitamin D3 actions on rhesus macaque follicles in three-dimensional culture: assessment of follicle survival, growth, steroid, and antimüllerian.
Endocrine disruptors and human reproductive failure: the in vitro effect of phthalates on human luteal cells  Federica Romani, M.D., Anna Tropea, M.D.,
Pathogenesis and pathophysiology of endometriosis
Expression of vascular endothelial growth factor-A and its receptor-1 in a luteal endometrium in patients with repeated in vitro fertilization failure 
Leukemia inhibitory factor induces cumulus expansion in immature human and mouse oocytes and improves mouse two-cell rate and delivery rates when it is.
Male contraception Fertility and Sterility
Akanksha Mehta, M.D., Mark Sigman, M.D.  Fertility and Sterility 
Fernando Zegers-Hochschild, M.D.  Fertility and Sterility 
Suppression and recovery of gonadotropin and steroid secretion by a gonadotropin- releasing hormone receptor antagonist in healthy women with normal ovulation.
Concentrations of stromal cell-derived factor-1 and vascular endothelial growth factor in relation to the diameter of human follicles  Akemi Nishigaki,
Michael M. Alper, M.D.  Fertility and Sterility 
2-Methoxyestradiol in the human corpus luteum throughout the luteal phase and its influence on lutein cell steroidogenesis and angiogenic activity  Paulina.
Fertility and Sterility
Aromatase, microRNA, and inflammation: a complex relationship
Progestins inhibit estradiol-induced vascular endothelial growth factor and stromal cell– derived factor 1 in human endometrial stromal cells  Hidetaka.
Dienogest inhibits nerve growth factor expression induced by tumor necrosis factor-α or interleukin-1β  Shizuka Mita, M.S., Yutaka Shimizu, Ph.D., Ayumi.
Federica Romani, M. D. , Antonio Lanzone, M. D. , Anna Tropea, M. D
Effect of the oxytocin antagonist antocin and agonist decomoton on baboon luteal cell production and release of progesterone  M. Yusoff Dawood, M.D.,
Regulation of catechol O-methyltransferase expression in granulosa cells: a potential role for follicular arrest in polycystic ovary syndrome  Sana M.
Medical treatment of ectopic pregnancy: a committee opinion
Transforming growth factor (TGF)-β1-induced human endometrial stromal cell decidualization through extracellular signal-regulated kinase and Smad activation.
Improvement of in vitro culture of mouse cumulus–oocyte complexes using PDE3- inhibitor followed by meiosis induction with epiregulin  Sergio Romero, M.Sc.,
Role of GnRH–GnRH receptor signaling at the maternal-fetal interface
The measurements of RAGE, VEGF, and AGEs in the plasma and follicular fluid of reproductive women: the influence of aging  Eriko Y. Fujii, M.D., Ph.D.,
Kisspeptin stimulates progesterone secretion via the Erk1/2 mitogen-activated protein kinase signaling pathway in rat luteal cells  Jing Peng, M.D., Min.
Oocyte cryopreservation
Growth hormone, insulin-like growth factor I, and leptin interaction in human cultured lutein granulosa cells steroidogenesis  Maria Karamouti, M.D, Panagoula.
Effect of aromatase inhibitors on ectopic endometrial growth and peritoneal environment in a mouse model of endometriosis  Mariela Bilotas, Ph.D., Gabriela.
Robert F. Casper, M.D.  Fertility and Sterility 
Impact of luteal phase support on pregnancy rates in intrauterine insemination cycles: a prospective randomized study  Ahmet Erdem, M.D., Mehmet Erdem,
Prokineticin 1, homeobox A10, and progesterone receptor messenger ribonucleic acid expression in primary cultures of endometrial stromal cells isolated.
Composition of commercial media used for human embryo culture
Effect of rejuvenation hormones on spermatogenesis
Rahi Victory, M. D. , F. R. C. S. C. , Ghassan M. Saed, Ph. D
A meta-analysis of the route of administration of luteal phase support in assisted reproductive technology: vaginal versus intramuscular progesterone 
Management of tubal ectopic pregnancy: methotrexate and salpingostomy are preferred to preserve fertility  Stephanie Beall, M.D., Ph.D., Alan H. DeCherney,
Aromatase inhibitor regulates let-7 expression and let-7f–induced cell migration in endometrial cells from women with endometriosis  SiHyun Cho, M.D.,
Modulation of HOXA10 and other markers of endometrial receptivity by age and human chorionic gonadotropin in an endometrial explant model  Robin H. Fogle,
Activin-A is induced by interleukin-1β and tumor necrosis factor-α and enhances the mRNA expression of interleukin-6 and protease-activated receptor-2.
Endocrine gland–derived vascular endothelial growth factor concentrations in follicular fluid and serum may predict ovarian hyperstimulation syndrome.
Prostaglandin-endoperoxide synthase (PTGS1 and PTGS2) expression and prostaglandin production by normal monkey ovarian surface epithelium  Rafael A. Cabrera,
Histone deacetylase inhibitors down-regulate G-protein-coupled estrogen receptor and the GPER-antagonist G-15 inhibits proliferation in endometriotic.
Roberto Ensenat-Waser, Ph. D. , Antonio Pellicer, M. D. , Ph. D
P53 tumor suppressor factor, plasminogen activator inhibitor, and vascular endothelial growth factor gene polymorphisms and recurrent implantation failure 
Effect of leptin on prolactin and insulin-like growth factor-I secretion by cultured rat endometrial stromal cells  Kamani H. Tennekoon, Ph.D., Thampoe.
Effects of growth hormone and insulin-like growth factor 1 on progesterone production in human luteinized granulosa cells  Toshiaki Taketani, M.D., Yoshiaki.
Effects of hyperglycemia on the differential expression of insulin and insulin-like growth factor-I receptors in human normal peritoneal and adhesion.
Human granulosa-lutein cell in vitro production of progesterone, inhibin A, inhibin B, and activin A are dependent on follicular size and not the presence.
Prokineticin 1 mRNA expression in the endometrium of healthy women and in the eutopic endometrium of women with endometriosis  Federica Tiberi, B.S.,
Reducing the dose of human chorionic gonadotropin in high responders does not affect the outcomes of in vitro fertilization  David W. Schmidt, M.D.,,
Fertility and Sterility: an evaluation
Upregulation of mRNA expression of vascular endothelial growth factor and its receptors by exogenous human chorionic gonadotropin in cultured oviduct.
Lipopolysaccharide-promoted proliferation of endometriotic stromal cells via induction of tumor necrosis factor α and interleukin-8 expression  Yumiko.
Lipopolysaccharide promoted proliferation and invasion of endometriotic stromal cells via induction of cyclooxygenase-2 expression  Yasuko Takenaka, M.D.,
Sodium nitroprusside treatment during the superovulation process improves ovarian response and ovarian expression of vascular endothelial growth factor.
Estrogen and selective estrogen receptor modulators regulate vascular endothelial growth factor and soluble vascular endothelial growth factor receptor.
Current evaluation of amenorrhea
Production of macrophage inflammatory protein-3α in human follicular fluid and cultured granulosa cells  Yasushi Kawano, M.D., Junichiro Fukuda, M.D.,
Resveratrol inhibits the mevalonate pathway and potentiates the antiproliferative effects of simvastatin in rat theca-interstitial cells  Donna H. Wong,
Direct injection of vascular endothelial growth factor into the ovary of mice promotes follicular development  Ramiro Quintana, M.D., Laura Kopcow, M.D.,
Serum anti-Mullerian hormone dynamics during stimulated cycles by aromatase inhibitor anastrozole and clomiphene citrate in women with infertility  H.-H.
A new era in ovulation induction
Prolactin inhibits oocyte release after gonadotropin stimulation in the rat: Putative mechanism involving ovarian production of beta-endorphin and prostaglandin 
In vitro sildenafil citrate use as a sperm motility stimulant
Transforming growth factor-β1 and its receptor soluble endoglin are altered in polycystic ovary syndrome during controlled ovarian stimulation  Reshef.
Progesterone level and progesterone/estradiol ratio on the day of hCG administration: detrimental cutoff levels and new treatment strategy  Eman A. Elgindy,
Endometrial polyps affect uterine receptivity
In vitro viability and secretory capacity of human luteinized granulosa cells after gonadotropin-releasing hormone agonist trigger of oocyte maturation 
Marita Pall, M. D. , Ph. D. , Margaret Nguyen, B. S
Presentation transcript:

Estrogens and androgens affect human luteal cell function Anna Tropea, M.D., Antonio Lanzone, M.D., Federica Tiberi, B.S., Federica Romani, M.D., Stefania Catino, M.L.T., Rosanna Apa, M.D.  Fertility and Sterility  Volume 94, Issue 6, Pages 2257-2263 (November 2010) DOI: 10.1016/j.fertnstert.2010.02.009 Copyright © 2010 American Society for Reproductive Medicine Terms and Conditions

Figure 1 (A) Effect of estrogens (Es) on basal P release by human luteal cells (LC). Human LC were cultured for 24 hours in medium alone (C, control) or with increasing concentrations of estrone (E1), E2, or estriol (E3) (from 3 × 10−7 M–3 × 10−5 M). Each value represents the mean ± SEM of 12 independent experiments, each done in triplicate. Results are expressed as a percentage of control set equal to 100. ***P<.001, **P<.01, *P<.05 versus control values. Different superscript letters indicate statistical differences (P<.05) among the different concentrations within each treatment (E1, E2, or E3); two columns with the same letter do not differ. (B) Effect of androgens on basal P release by human LC. Human LC were cultured for 24 hours in medium alone (control) or with of T, androstendione (A), or dihydrotestosterone (DHT) (from 10−11 M–10−7 M). The figure shows increasing concentrations of androgens starting from the highest ineffective dose. Each value represents the mean ± SEM of 12 independent experiments, each done in triplicate. Results are expressed as a percentage of control set equal to 100. ***P<.001, **P<.01, *P<.05 versus control values. Different superscript letters indicate statistical differences (P<.05) among the different concentrations within each treatment (T, A, or DHT); two columns with the same letter do not differ. (C) Effect of estrogens (Es) on hCG-stimulated P release by human LC. Human LC were cultured for 24 hours in medium alone (control) or with hCG (100 ng/mL) in combination or not with E1, E2, or E3 (3 ×10−5 M). Each value represents the mean ± SEM of 12 independent experiments, each done in triplicate. Results are expressed as a percentage of control set equal to 100. °°°P<.001 versus control values; ***P<.01 versus hCG values. (D) Effect of androgens on hCG-stimulated P release by human LC. Human LC were cultured for 24 hours in medium alone (control) or with hCG (100 ng/mL) in combination or not with T, A, or DHT (10−7 M). Each value represents the mean ± SEM of 12 independent experiments, each done in triplicate. Results are expressed as a percentage of control set equal to 100. °°°P<.001 versus control values; ***P<.001, **P<.01 versus hCG values. Fertility and Sterility 2010 94, 2257-2263DOI: (10.1016/j.fertnstert.2010.02.009) Copyright © 2010 American Society for Reproductive Medicine Terms and Conditions

Figure 2 (A) Effects of estrogens (Es) on prostaglandin (PG) F2α release by human luteal cells (LC). Human LC were cultured for 24 hours in medium alone (C, control) or with estrone (E1), E2, or estriol (E3) (from 3 × 10−7 M–3 × 10−5 M). Each value represents the mean ± SEM of 12 independent experiments, each done in triplicate. Results are expressed as a percentage of control set equal to 100. ***P<.001, *P<.05 versus control values. Different superscript letters indicate statistical differences (P<.05) among the different concentrations within each treatment (E1, E2, or E3); two columns with the same letter do not differ. (B) Effects of androgens on PGF2α release by human LC. Human LC were cultured for 24 hours in medium alone (control) or with T, androstendione (A), or dihydrotestosterone (DHT) (from 10−11 M–10−7 M). The figure shows increasing concentrations of androgens starting from the highest ineffective dose. Each value represents the mean ± SEM of 12 independent experiments, each done in triplicate. Results are expressed as a percentage of control set equal to 100. ***P<.001, **P<.01, *P<.05 versus control values. Different superscript letters indicate statistical differences among the different concentrations within each treatment (T, A, or DHT); two columns with the same letter do not differ (P<.05). (C) Effect of Es on PGE2 release in human LC. Human LC were cultured for 24 hours in medium alone (control) or with increasing concentration of E1, E2, or E3 (from 3 × 10−7 M–3 × 10−5 M). Each value represents the mean ± SEM of 12 independent experiments, each done in triplicate. Results are expressed as a percentage of control set equal to 100. ***P<.001 versus control values. Different superscript letters indicate statistical differences (P<.05) among the different concentrations within each treatment (E1, E2, or E3); two columns with the same letter do not differ. Fertility and Sterility 2010 94, 2257-2263DOI: (10.1016/j.fertnstert.2010.02.009) Copyright © 2010 American Society for Reproductive Medicine Terms and Conditions

Figure 3 (A) Effect of estrogens (Es) on vascular endothelial growth factor (VEGF) release in human luteal cells (LC). Human LC were cultured for 24 hours in medium alone (C, control), with CoCl2 (10 μM), or in the presence of estrone (E1), E2, or estriol (E3) (from 3 × 10−7 M–3 × 10−5 M). Each value represents the mean ± SEM of 12 independent experiments, each done in triplicate. Results are expressed as a percentage of control set equal to 100. ***P<.001, **P<.01 versus control values. Different superscript letters indicate statistical differences (P<.05) among the different concentrations within each treatment (E1, E2, or E3); two columns with the same letter do not differ. (B) Effect of androgens on VEGF release in human LC. Human LC were cultured for 24 hours in medium alone (control), with CoCl2 (10 μM), or in presence of T, androstendione (A), or dihydrotestosterone (DHT) (from 10−11 M–10−7 M). Each value represents the mean ± SEM of 12 independent experiments, each done in triplicate. Results are expressed as a percentage of control set equal to 100. ***P<.001, **P<.01, *P<.05 versus control values. Different superscript letters indicate statistical differences (P<.05) among the different concentrations within each treatment (T, A, or DHT); two columns with the same letter do not differ. Fertility and Sterility 2010 94, 2257-2263DOI: (10.1016/j.fertnstert.2010.02.009) Copyright © 2010 American Society for Reproductive Medicine Terms and Conditions

Figure 4 (A) Effect of aromatase inhibitor (AI) alone or in presence of androgens on P release by human luteal cells (LC). Human LC were cultured for 24 hours in medium alone (C, control) or in presence of AI (4 nM) with or without T or androstendione (A) (10−7 M). Each value represents the mean ± SEM of 12 independent experiments, each done in triplicate. Results are expressed as a percentage of control set equal to 100. ***P<.001, **P<.01 vs. control values. (B) Effects of AI alone or in presence of androgens on prostaglandin (PG)F2α release by human LC. Human LC were cultured for 24 hours in medium alone (control) or in presence of AI (4 nM) with or without T or A (10−7 M). Each value represents the mean ± SEM of 12 independent experiments, each done in triplicate. Results are expressed as a percentage of control set equal to 100. ***P<.001, **P<.01 versus control values. (C) Effect of AI alone or in the presence of androgens on vascular endothelial growth factor (VEGF) release in human LC. Human LC were cultured for 24 hours in medium alone (control) or in presence of AI (4 nM) with or without T or A (10−7 M). Each value represents the mean ± SEM of 12 independent experiments, each done in triplicate. Results are expressed as a percentage of control set equal to 100. ***P<.001 versus control values. (D) Effect of AI on PGE2 release in human LC. Human LC were cultured for 24 hours in medium alone (control) or in the presence of AI (4 nM). Each value represents the mean ± SEM of 12 independent experiments, each done in triplicate. Results are expressed as a percentage of control set equal to 100. ***P<.001 versus control values. Fertility and Sterility 2010 94, 2257-2263DOI: (10.1016/j.fertnstert.2010.02.009) Copyright © 2010 American Society for Reproductive Medicine Terms and Conditions